Skip Navigation
  1. IPA Joins Indiana Coalition for Patient-Centered Care (ICPCC)
  2. HB-1246: Gabapentin INSPECT Clarification

HB-1246: Gabapentin INSPECT Clarification

By IPA on 6/24/2019

This recently signed 2019 bill intended gabapentin to be a “controlled substance” for the purposes of INSPECT only (and not outside of INSPECT). We have confirmed with the Indiana Board of Pharmacy that is how they have interpreted the law- it is not scheduled, just as to be reported.